Skip to content
ClinCalc Pro
Menu
ophthalmology paediatrics

Refractive Error & Myopia Severity Classification

International Myopia Institute classification (IMI 2019). Spherical equivalent (SE) refraction in dioptres after cycloplegic refraction in children. Higher myopia confers greater lifetime risk of myopic maculopathy, retinal detachment, glaucoma, and cataract.

Score interpretation

Significant hyperopia -2

→ Children: cycloplegic refraction; treat amblyopia and accommodative esotropia with full correction. Adults: spectacles/contact lenses; assess for asthenopia and angle closure risk.

Low hyperopia / emmetropia -1–0

→ No treatment indicated unless symptomatic. Routine optometry interval.

Low myopia 1

→ Spectacles/contacts. In children: discuss myopia control (atropine 0.01–0.05%, dual-focus contact lenses, MiSight, orthokeratology) per IMI 2021. Outdoor time ≥2 h/day.

Moderate myopia 2

→ Active myopia-control intervention strongly indicated in children. Annual review for posterior segment changes (lattice, atrophic patches). Discuss elevated lifetime retinal detachment risk.

High myopia (≥6 D) 3

→ Posterior segment surveillance (OCT macula + dilated peripheral retina) every 1–2 years. Counsel on symptoms of detachment (flashes/floaters/curtain). Avoid contact sports if peripheral degenerations. Consider posterior staphyloma / myopic maculopathy. Refractive surgery options if stable; ICL preferred over LASIK above ~−10 D.

Severe / pathological myopia 4

→ Annual macular OCT + ultra-widefield imaging. Treat myopic CNV (anti-VEGF — NICE TA298 ranibizumab). Lifelong follow-up; vision rehabilitation. Counsel on hereditary risk and intervention in offspring.

Interpretation bands for the Myopia Severity. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.